Back
Brainstorm Cell Therapeutics, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
57
BCLI
Brainstorm Cell Therapeutics, Inc.
Last Price:
$0.67
Seasonality Move:
24.38%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BCLI is experiencing buying pressure, which is a positive indicator for future bullish movement.
Brainstorm Cell Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.58 | Buy |
| 20-day SMA: | 0.59 | Buy |
| 50-day SMA: | 0.63 | Buy |
| 200-day SMA: | 0.89 | Sell |
| 8-day EMA: | 0.6 | Buy |
| 20-day EMA: | 0.6 | Buy |
| 50-day EMA: | 0.63 | Buy |
| 200-day EMA: | 0.85 | Sell |
Brainstorm Cell Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.01 | Sell |
| Relative Strength Index (14 RSI): | 59.15 | Buy |
| Chaikin Money Flow: | 88262 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.57 - 0.63) | Buy |
| Bollinger Bands (100): | (0.61 - 0.71) | Buy |
Brainstorm Cell Therapeutics, Inc. Technical Analysis
| Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 24 | Dec 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 24 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Brainstorm Cell Therapeutics, Inc. Stock
Is Brainstorm Cell Therapeutics, Inc. Stock a Buy?
-
Brainstorm Cell Therapeutics, Inc. share price is 0.67 while BCLI 8-day simple moving average is 0.58, which is a Buy signal.
-
The stock price of BCLI is 0.67 while Brainstorm Cell Therapeutics, Inc. 20-day SMA is 0.59, which makes it a Buy.
-
Brainstorm Cell Therapeutics, Inc. 50-day simple moving average is 0.63 while BCLI share price is 0.67, making it a Buy technically.
-
BCLI stock price is 0.67 and Brainstorm Cell Therapeutics, Inc. 200-day simple moving average is 0.89, creating a Sell signal.
BCLI Technical Analysis vs Fundamental Analysis
Buy
57
Brainstorm Cell Therapeutics, Inc. (BCLI)
is a Buy
Is Brainstorm Cell Therapeutics, Inc. a Buy or a Sell?
-
Brainstorm Cell Therapeutics, Inc. stock is rated a BuyThe current Brainstorm Cell Therapeutics, Inc. [BCLI] share price is $0.67. The Score for BCLI is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
Brainstorm Cell Therapeutics, Inc. Stock Info
Market Cap:
7.4M
Price in USD:
0.67
Share Volume:
114.1K
Brainstorm Cell Therapeutics, Inc. 52-Week Range
52-Week High:
2.49
52-Week Low:
0.52
Buy
57
Brainstorm Cell Therapeutics, Inc. (BCLI)
is a Buy
Brainstorm Cell Therapeutics, Inc. Share Price Forecast
-
What is the Brainstorm Cell Therapeutics, Inc. stock price today?The Brainstorm Cell Therapeutics, Inc. stock price is 0.67 USD today.
-
Will BCLI stock go up or go down?Brainstorm Cell Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Brainstorm Cell Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Brainstorm Cell Therapeutics, Inc. is not overvalued.
Is Brainstorm Cell Therapeutics, Inc. Stock a Buy?
-
Brainstorm Cell Therapeutics, Inc. share price is 0.67 while BCLI 8-day exponential moving average is 0.60, which is a Buy signal.
-
The stock price of BCLI is 0.67 while Brainstorm Cell Therapeutics, Inc. 20-day EMA is 0.60, which makes it a Buy.
-
Brainstorm Cell Therapeutics, Inc. 50-day exponential moving average is 0.63 while BCLI share price is 0.67, making it a Buy technically.
-
BCLI stock price is 0.67 and Brainstorm Cell Therapeutics, Inc. 200-day simple moving average is 0.85, creating a Sell signal.
Fundamental Analysis of Brainstorm Cell Therapeutics, Inc.
Is Brainstorm Cell Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.49 per share, and an increase next year of $0.54 per share.
Technical Analysis of Brainstorm Cell Therapeutics, Inc.
Should I short Brainstorm Cell Therapeutics, Inc. stock?
-
BCLI Moving Average Covergence Divergence (MACD) indicator is -0.01, suggesting Brainstorm Cell Therapeutics, Inc. is a Sell
-
Brainstorm Cell Therapeutics, Inc. Relative Strength Index (RSI) is 59.15, which suggest Brainstorm Cell Therapeutics, Inc. is overbought
-
The Bollinger Bands (25) for Brainstorm Cell Therapeutics, Inc. is (0.57 - 0.63), which suggest Brainstorm Cell Therapeutics, Inc. is a Buy
-
The Bollinger Bands (100) for Brainstorm Cell Therapeutics, Inc. is (0.61 - 0.71), which suggest Brainstorm Cell Therapeutics, Inc. is a Buy
* Brainstorm Cell Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.